 |
|
Mutation Analysis of Oculopharyngeal Muscular Dystrophy in Hispanic American Families
Raji P. Grewal, MD;
Jayaprakash D. Karkera, PhD;
Roopinder K. Grewal, MD;
Sevilla D. Detera-Wadleigh, PhD
Arch Neurol. 1999;56:1378-1381.
Background Oculopharyngeal muscular dystrophy (OPMD) is a late-onset autosomal dominant muscular dystrophy characterized by progressive ptosis, swallowing difficulties, and proximal limb weakness. Recently, the genetic basis of this disease has been characterized by mutations in the PABP2 gene that involve short expansions of the trinucleotide repeat GCG.
Objectives To independently confirm the presence and study the meiotic stability of the GCG expansion mutations in a distinct ethnic population with OPMD.
Settings Hospital and university research laboratories in Los Angeles, Calif.
Subjects and Methods Three unrelated families of Hispanic American descent were identified in whom OPMD was transmitted in an autosomal dominant pattern. All of these families can trace affected ancestors to the southwestern United States or to the bordering states of Mexico. In these families, 14 persons with OPMD were identified and studied.
Results Our results confirm that in these families, expansion mutations characterized by a gain of 3 GCG repeats in the wild-type allele result in an abnormal nucleotide length of 9 GCG repeats in the PABP2 gene. In these families, these mutations are associated with the OPMD phenotype. The identical repeat mutation ([GCG]9) is found in all affected members of these unrelated families and shows relative meiotic stability.
Conclusions These results support and extend our study of haplotype analysis and suggest that a founder effect may have occurred for OPMD in this Hispanic American population.
From the Departments of Neurology (Dr R. P. Grewal), University of Southern California School of Medicine, Los Angeles, and Ophthalmology (Dr R. K. Grewal), Kaiser Permanente Medical Center, West Los Angeles; and the Unit on Gene Mapping and Expression (Drs Karkera and Detera-Wadleigh), Clinical Neurogenetics Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, Md.
RELATED ARTICLE
Archives of Neurology Reader's Choice: Continuing Medical Education
Arch Neurol. 1999;56(11):1421-1422.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Oculopharyngeal Muscular Dystrophy in Hispanic New Mexicans
Becher et al.
JAMA 2001;286:2437-2440.
ABSTRACT
| FULL TEXT
Oligomerization of polyalanine expanded PABPN1 facilitates nuclear protein aggregation that is associated with cell death
Fan et al.
Hum Mol Genet 2001;10:2341-2351.
ABSTRACT
| FULL TEXT
Oculopharyngeal muscular dystrophy: Phenotypic and genotypic studies in a UK population
Hill et al.
Brain 2001;124:522-526.
ABSTRACT
| FULL TEXT
|
